Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Syncom Formulation (India) Ltd

NSE: SYNCOMF · BSE: 524470 · Pharmaceuticals & Biotechnology · 7 announcements

Share price
₹20.05
Market cap
₹1,885 Cr
Revenue (annual)
₹489.2 Cr
Net profit (annual)
₹76.44 Cr
P/E (TTM)
22.0×Sector 50.4×
Promoter holding
50.57%+0.00% QoQ
FII holding
0.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:16 IST BSE
Other Announcement

Syncom Formulation (India) Other Announcement

Syncom Formulations' promoters have voluntarily waived their right to the proposed final dividend of ₹0.10 per share. This waiver reduces total dividend payout obligations.

Value
₹4.75 Cr
11:49 IST BSE
Other Announcement

Syncom Formulation (India) Other Announcement

Syncom Formulations fixed 23 Sep 2026 as record date for a proposed 10% dividend (Rs.0.10/share) pending AGM approval. The 38th AGM is scheduled for 30 Sep 2026.

19:06 IST BSE
Other Announcement

Syncom Formulation (India) Other Announcement

Syncom Formulations (India) Limited informed exchanges about the dispatch of letters to shareholders with unregistered email addresses, providing instructions to access the 38th AGM Notice and Annual Report.